#term ID;term description;observed gene count;background gene count;strength;false discovery rate;matching proteins in your network (labels)
GO:0045628;regulation of T-helper 2 cell differentiation;2;11;2.06;0.0448;HLX,PRKCZ
GO:0060174;limb bud formation;2;11;2.06;0.0448;WNT3,FGFR2
GO:0050927;positive regulation of positive chemotaxis;3;26;1.86;0.0097;S1PR1,F3,VEGFA
GO:0061180;mammary gland epithelium development;3;57;1.52;0.0371;WNT3,AREG,FGFR2
GO:0030879;mammary gland development;5;126;1.4;0.0058;WNT3,TGFB3,AREG,FGFR2,VEGFA
GO:0060560;developmental growth involved in morphogenesis;4;116;1.34;0.0196;S1PR1,PRKCZ,AREG,FGFR2
GO:0010811;positive regulation of cell-substrate adhesion;4;124;1.31;0.0233;NID1,FBLN1,PRKCZ,VEGFA
GO:0048639;positive regulation of developmental growth;5;176;1.25;0.0082;WNT3,HLX,FGFR2,VEGFA,CDH4
GO:0010810;regulation of cell-substrate adhesion;5;212;1.17;0.0134;NID1,PDPN,FBLN1,PRKCZ,VEGFA
GO:0030324;lung development;4;170;1.17;0.0422;TGFB3,PDPN,FGFR2,VEGFA
GO:0030177;positive regulation of Wnt signaling pathway;4;182;1.14;0.0457;WNT3,GPRC5B,ROR2,FGFR2
GO:0010769;regulation of cell morphogenesis involved in differentiation;5;309;1.01;0.0371;WNT3,PDPN,FBLN1,VEGFA,CDH4
GO:0048732;gland development;6;410;0.97;0.0213;WNT3,TGFB3,HLX,AREG,FGFR2,VEGFA
GO:0045785;positive regulation of cell adhesion;6;423;0.95;0.0233;NID1,PDPN,FBLN1,HLX,PRKCZ,VEGFA
GO:0042060;wound healing;6;439;0.94;0.0271;TGFB3,PDPN,FBLN1,F3,FGFR2,VEGFA
GO:0008285;negative regulation of cell population proliferation;9;696;0.91;0.0058;TGFB3,PDPN,CLMN,FBLN1,DPT,ROR2,CXCL1,ATF5,FGFR2
GO:0048812;neuron projection morphogenesis;6;495;0.88;0.0371;WNT3,FLRT2,PRKCZ,FGFR2,VEGFA,CDH4
GO:0071363;cellular response to growth factor stimulus;6;494;0.88;0.0371;TGFB3,FLRT2,ROR2,PRKCZ,FGFR2,VEGFA
GO:0031175;neuron projection development;8;680;0.87;0.0082;WNT3,CLMN,FLRT2,PRKCZ,AREG,FGFR2,VEGFA,CDH4
GO:0030335;positive regulation of cell migration;6;522;0.86;0.0422;PDPN,S1PR1,FBLN1,F3,ROR2,VEGFA
GO:0033674;positive regulation of kinase activity;7;624;0.85;0.0233;TGFB3,GPRC5B,ROR2,PRKCZ,AREG,FGFR2,VEGFA
GO:0048666;neuron development;9;827;0.84;0.0058;WNT3,CLMN,FLRT2,PRKCZ,AREG,ATF5,FGFR2,VEGFA,CDH4
GO:0006935;chemotaxis;6;545;0.84;0.0454;WNT3,S1PR1,FLRT2,CXCL1,VEGFA,CDH4
GO:0045860;positive regulation of protein kinase activity;6;550;0.84;0.0457;TGFB3,GPRC5B,ROR2,PRKCZ,AREG,VEGFA
GO:0051962;positive regulation of nervous system development;6;547;0.84;0.0457;WNT3,GPRC5B,FLRT2,ROR2,VEGFA,CDH4
GO:0048729;tissue morphogenesis;6;561;0.83;0.0491;WNT3,PDPN,S1PR1,AREG,FGFR2,VEGFA
GO:0042127;regulation of cell population proliferation;16;1642;0.79;9.91e-06;WNT3,TGFB3,PDPN,CLMN,S1PR1,FBLN1,F3,HLX,DPT,ROR2,PRKCZ,AREG,CXCL1,ATF5,FGFR2,VEGFA
GO:0030182;neuron differentiation;10;1019;0.79;0.0058;WNT3,CLMN,S1PR1,FLRT2,PRKCZ,AREG,ATF5,FGFR2,VEGFA,CDH4
GO:0008284;positive regulation of cell population proliferation;9;919;0.79;0.0082;TGFB3,S1PR1,FBLN1,F3,HLX,PRKCZ,AREG,FGFR2,VEGFA
GO:0007167;enzyme linked receptor protein signaling pathway;7;720;0.79;0.0371;TGFB3,FLRT2,ROR2,PRKCZ,AREG,FGFR2,VEGFA
GO:0030155;regulation of cell adhesion;7;712;0.79;0.0371;NID1,PDPN,S1PR1,FBLN1,HLX,PRKCZ,VEGFA
GO:0000902;cell morphogenesis;7;726;0.78;0.0371;WNT3,PDPN,FLRT2,PRKCZ,FGFR2,VEGFA,CDH4
GO:0045597;positive regulation of cell differentiation;9;993;0.76;0.0113;WNT3,TGFB3,PDPN,GPRC5B,HLX,ROR2,PRKCZ,VEGFA,CDH4
GO:0120036;plasma membrane bounded cell projection organization;10;1122;0.75;0.0067;WNT3,PDPN,CLMN,S1PR1,FLRT2,PRKCZ,AREG,FGFR2,VEGFA,CDH4
GO:0051094;positive regulation of developmental process;12;1389;0.74;0.0058;WNT3,TGFB3,PDPN,GPRC5B,FLRT2,F3,HLX,ROR2,PRKCZ,FGFR2,VEGFA,CDH4
GO:0009887;animal organ morphogenesis;8;967;0.72;0.0371;TGFB3,S1PR1,FLRT2,HLX,ROR2,AREG,FGFR2,VEGFA
GO:0040012;regulation of locomotion;8;969;0.72;0.0371;WNT3,PDPN,S1PR1,FBLN1,FLRT2,F3,ROR2,VEGFA
GO:0060284;regulation of cell development;8;956;0.72;0.0371;WNT3,PDPN,GPRC5B,FBLN1,FLRT2,ROR2,VEGFA,CDH4
GO:0007267;cell-cell signaling;9;1145;0.7;0.0236;WNT3,NID1,FGF11,DLGAP1,AMPH,ROR2,AREG,FGFR2,GRIA1
GO:0051270;regulation of cellular component movement;8;1009;0.7;0.0391;WNT3,PDPN,S1PR1,FBLN1,FLRT2,F3,ROR2,VEGFA
GO:0048699;generation of neurons;12;1551;0.69;0.0058;WNT3,CLMN,GPRC5B,S1PR1,FLRT2,ROR2,PRKCZ,AREG,ATF5,FGFR2,VEGFA,CDH4
GO:1902533;positive regulation of intracellular signal transduction;8;1041;0.69;0.0435;TGFB3,GPRC5B,F3,ROR2,PRKCZ,AREG,FGFR2,VEGFA
GO:0051240;positive regulation of multicellular organismal process;13;1770;0.67;0.0058;WNT3,TGFB3,PDPN,GPRC5B,FLRT2,F3,OPRL1,HLX,ROR2,PRKCZ,FGFR2,VEGFA,CDH4
GO:0043085;positive regulation of catalytic activity;11;1489;0.67;0.0082;TGFB3,GPRC5B,S1PR1,FBLN1,F3,ROR2,PRKCZ,AREG,CXCL1,FGFR2,VEGFA
GO:0040011;locomotion;9;1251;0.66;0.0371;WNT3,PDPN,S1PR1,FLRT2,ROR2,PRKCZ,CXCL1,VEGFA,CDH4
GO:0045595;regulation of cell differentiation;13;1874;0.64;0.0058;WNT3,TGFB3,PDPN,GPRC5B,FBLN1,FLRT2,HLX,ROR2,PRKCZ,AREG,FGFR2,VEGFA,CDH4